Stay updated on IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page
- ChecktodayChange DetectedThe completed study record for the indoximod and chemotherapy trial is now displayed, with details on its design, participants, treatments, outcomes, and record documents.SummaryDifference63%

- Check7 days agoChange DetectedThe ClinicalTrials.gov page footer shows an updated site revision number, while the study record remains unavailable.SummaryDifference0.2%

- Check21 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check28 days agoChange DetectedThe revision label in the page footer changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check49 days agoChange DetectedThe study record page now renders a 403 Forbidden error screen, replacing the study content and sponsor/document links with a standard error page.SummaryDifference20%

- Check71 days agoChange DetectedThe page's revision label has been updated from v3.6.5 to v3.6.6, indicating a minor update to the page's revision history rather than substantive changes to the study details.SummaryDifference0.0%

Stay in the know with updates to IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.